APRI, GPR, FIB-4, and S-Index were found to perform better than other non-invasive markers for determining advanced liver fibrosis and cirrhosis in our study; their sensitivity and specificity were limited for significant fibrosis. This evidence concerns the gene ALDH18A1 and Hepatic fibrosis.